Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Altimmune, Inc.
- Maze Therapeutics, Inc.
Updated Jul 16, 2026
Sohn Catherine A. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.15M.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-08 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 26.9K | $39.11 | $1.05M |
| 2026-01-08 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 3.3K | $10.42 | $34K |
| 2026-01-08 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 2.9K | $10.42 | $30K |
| 2026-01-08 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 20.7K | $10.42 | $216K |
| 2026-01-08 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 2.5K | $38.62 | $96K |
| 2026-01-08 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 2.5K | $10.42 | $26K |
Sohn Catherine A. is a corporate insider — currently tracked as Insider of Altimmune, Inc. (ALT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.15M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sohn Catherine A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.